Seung Hwan Lee’s team developed dBhCas12b-ABE, a Cas12b adenine base editor targeting T-rich PAMs that suppresses indels to 0–0.04% and offers tunable editing windows. 🧬🤖 #CRISPR #BaseEditing #Cas12b #MolecularTherapy #GeneEditing #ChungAngUniversity
October 9, 2026 at 10:06 AM
Seung Hwan Lee’s team developed dBhCas12b-ABE, a Cas12b adenine base editor targeting T-rich PAMs that suppresses indels to 0–0.04% and offers tunable editing windows. 🧬🤖 #CRISPR #BaseEditing #Cas12b #MolecularTherapy #GeneEditing #ChungAngUniversity